AI Vaccine Clears Human Trials, Handing Pharma a New Playbook (opens in new tab)

A vaccine designed entirely by artificial intelligence (AI) has cleared its first human safety trial. The vaccine, developed by the University of Cambridge and its spinout DIOSynVax, was found safe and well tolerated, ScienceDaily reported Friday (June 5). The AI model didn’t work from a known pathogen. It analyzed surveillance data from virus populations […] The post appeared first on <a href="